Shattuck Labs Stock (NASDAQ: STTK) stock price, news, charts, stock research, profile.
Open | $9.630 |
Close | $9.780 |
Volume / Avg. | 112.347K / 323.818K |
Day Range | 9.466 - 9.890 |
52 Wk Range | 1.330 - 11.110 |
Market Cap | $465.048M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 5.73% |
Days to Cover | 5.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Shattuck Labs (NASDAQ: STTK) through any online brokerage.
Other companies in Shattuck Labs’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Celcuity (NASDAQ:CELC), Larimar Therapeutics (NASDAQ:LRMR) and Altimmune (NASDAQ:ALT).
The latest price target for Shattuck Labs (NASDAQ: STTK) was reported by Needham on Tuesday, April 9, 2024. The analyst firm set a price target for 12.00 expecting STTK to rise to within 12 months (a possible 22.70% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Shattuck Labs (NASDAQ: STTK) is $9.78 last updated April 25, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Shattuck Labs.
Shattuck Labs’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Shattuck Labs.
Shattuck Labs is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.